1,2,7,8-tetrachlorodibenzofuran
weak inhibitor of insulin-like growth factor-I
Also Known As:
1,2,7,8-TCDF
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
| 1. | Hepatocellular Carcinoma (Hepatoma)
08/01/1989
- " Treatment of rat hepatoma H-4-IIE cells in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,7,8-tetrachlorodibenzofuran (TCDF), 1,2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD), 1,2,3,7,8-pentachlorodibenzofuran (PeCDF), 1,2,7,8-TCDF, and 2,3,7-trichlorodibenzo-p-dioxin (TrCDD) resulted in the structure-dependent induction of aryl hydrocarbon hydroxylase and ethoxyresorufin O-deethylase activities. "
|
|
Related Drugs and Biologics
| 1. | Cytochrome P-450 CYP1A1 (CYP1A1)
|
| 2. | Mixed Function Oxygenases (Monooxygenases)
|
| 3. | Hydrocarbons
|
| 4. | Polychlorinated Dibenzodioxins (TCDD)
|
| 5. | 1,2,3,7,8-pentachlorodibenzofuran
|
| 6. | 1,2,3,7,8-pentachlorodibenzo-p-dioxin
|
| 7. | 2,3,7,8-tetrachlorodibenzofuran
|
|